| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |